Immunovant Down Over 7%, On Pace for Largest Percent Decrease Since July 2025 -- Data Talk
Dow Jones2026/09/23 17:52Immunovant Inc. (IMVT) is currently at $34.60, down $2.70 or 7.23%
--Would be lowest close since June 16, 2026, when it closed at $33.61
--On pace for largest percent decrease since July 25, 2025, when it fell 7.48%
--Snaps a two day winning streak
--Down 15.25% month-to-date; on pace for worst month since March 2025, when it fell 17.04%
--Up 36.09% year-to-date
--Down 34.37% from its all-time closing high of $52.71 on Nov. 17, 2020
--Up 123.77% from 52 weeks ago (Sept. 24, 2025), when it closed at $15.46
--Down 23.05% from its 52-week closing high of $44.96 on Aug. 19, 2026
--Up 123.77% from its 52-week closing low of $15.46 on Sept. 24, 2025
--Traded as low as $33.60; lowest intraday level since June 16, 2026, when it hit $32.86
--Down 9.9% at today's intraday low; largest intraday percent decrease since July 25, 2025, when it fell as much as 16.43%
All data as of 1:49:41 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 23, 2026 13:52 ET (17:52 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.